We are live on ! Find out more
ELAN icon

Elanco Animal Health

376 hedge funds and large institutions have $9.85B invested in Elanco Animal Health in 2019 Q3 according to their latest regulatory filings, with 77 funds opening new positions, 158 increasing their positions, 100 reducing their positions, and 70 closing their positions.

New
Increased
Maintained
Reduced
Closed

58% more repeat investments, than reductions

Existing positions increased: 158 | Existing positions reduced: 100

10% more first-time investments, than exits

New positions opened: 77 | Existing positions closed: 70

2% more funds holding

Funds holding: 370376 (+6)

2.91% less ownership

Funds ownership: 102.54%99.62% (-2.9%)

22% less capital invested

Capital invested by funds: $12.6B → $9.85B (-$2.79B)

43% less funds holding in top 10

Funds holding in top 10: 74 (-3)

50% less call options, than puts

Call options by funds: $24.6M | Put options by funds: $49.3M

Holders
376
Holders Change
+6
Holders Change %
+1.62%
% of All Funds
8.25%
Holding in Top 10
4
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-42.86%
% of All Funds
0.09%
New
77
Increased
158
Reduced
100
Closed
70
Calls
$24.6M
Puts
$49.3M
Net Calls
-$24.7M
Net Calls Change
-$20.1M
Name Holding Trade Value Shares
Change
Change in
Stake
FLPIM
251
F.L. Putnam Investment Management
Massachusetts
$389K +$438K +14,615 New
BAM
252
Barrett Asset Management
New York
$386K -$1.62M -53,880 -79%
PCM
253
Pentwater Capital Management
Florida
$385K -$241K -8,017 -36%
NIT
254
NumerixS Investment Technologies
British Columbia, Canada
$383K -$57K -1,900 -12%
AIM
255
Achmea Investment Management
Netherlands
$379K
SB
256
Suntrust Banks
Georgia
$379K +$142K +4,724 +50%
SIC
257
SFE Investment Counsel
California
$370K +$418K +13,930 New
SM
258
Sciencast Management
New Jersey
$369K +$410K +13,675 New
BCM
259
Bayesian Capital Management
New York
$366K +$412K +13,746 New
Comerica Bank
260
Comerica Bank
Texas
$364K -$44.5K -1,482 -10%
BUB
261
BBVA USA Bancshares
Texas
$336K +$9.81K +327 +3%
Northwestern Mutual Wealth Management
262
Northwestern Mutual Wealth Management
Wisconsin
$335K +$339K +11,288 +848%
GC
263
Guggenheim Capital
Illinois
$332K -$27.4K -915 -7%
LTFS
264
Ladenburg Thalmann Financial Services
Florida
$331K +$77.3K +2,576 +26%
MC
265
Moors & Cabot
Massachusetts
$323K +$362K +12,050 New
QSS
266
Quantitative Systematic Strategies
Florida
$321K -$400K -13,329 -52%
AG
267
Aperio Group
California
$312K +$272K +9,052 +339%
FMWA
268
Forvis Mazars Wealth Advisors
Missouri
$307K +$45.5K +1,516 +15%
TC
269
Telemus Capital
Michigan
$298K +$336K +11,215 New
Brown Advisory
270
Brown Advisory
Maryland
$296K +$14.3K +475 +4%
TI
271
Trexquant Investment
Connecticut
$291K -$424K -14,148 -56%
Verition Fund Management
272
Verition Fund Management
Connecticut
$290K +$140K +4,675 +75%
OAM
273
Oppenheimer Asset Management
New York
$274K +$4.68K +156 +2%
DTL
274
Dynamic Technology Lab
Singapore
$265K +$299K +9,979 New
PHK
275
Point72 Hong Kong
Hong Kong
$260K -$83.1K -2,769 -22%

ELAN Hedge Fund Activity: Q3 2019 in Review

376 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Elanco Animal Health (ELAN) for Q3 2019, worth a combined $9.85B — down 22% from $12.6B a quarter earlier.

Buyers outnumbered sellers: 77 funds opened new ELAN positions and 70 closed out — a net gain of 7 holders — while 158 added to existing stakes and 100 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $212M. The largest seller was T. Rowe Price Associates, cutting an estimated $153M.

  • 376 institutional investors held Elanco Animal Health (ELAN) as of Q3 2019, up from 370 in Q2 2019.
  • Funds reported $9.85B of Elanco Animal Health stock for Q3 2019, down 22% quarter-over-quarter.
  • 77 funds opened new Elanco Animal Health positions in Q3 2019 and 70 closed out, a net change of +7 holders.
  • The largest Elanco Animal Health buyer in Q3 2019 was Wellington Management Group, an estimated $212M added.
  • The largest Elanco Animal Health seller in Q3 2019 was T. Rowe Price Associates, an estimated $153M sold.

Based on aggregated 13F filings for Q3 2019.